ATHA (athira.com) Prakiraan pendapatan perusahaan

Athira Pharma Inc - logo grafis emiten ATHA

Athira Pharma, Inc. (ATHA) is currently reviewing its assets due to testing issues, which is leading to increased restructuring costs. The automation of molecule screening is accelerating their scientific research. The revenue forecast on the GURU.Markets chart, where the 0.00 metric reflects current dynamics, highlights the potential of this Alzheimer's therapy innovator, which restores neural connections via HGF technology.

ATHA - Pendapatan mangsa ngarep perusahaan Athira Pharma Corp ing rentang 04.07.2022 - 12.01.2026

Rincian metrik keuangan lan pasar Athira Pharma Corp (ATHA)

- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
Analisis fundamental perusahaan:athira.com
Produk mawa merek Athira

This metric determines the potential for generating future cash flows, uncovering hidden business vulnerabilities during periods of market optimism. The calculation is based on assessing the issuer's ability to scale commercial revenues through a series of sustainable highs. By analyzing the company's prospective revenue, an investor evaluates the real pace of operational expansion. For Athira Pharma, Inc. (ATHA), this reflects market demand for unique neuroregenerative drugs. The trend confirms the commercial viability of methods for combating Alzheimer's disease.

Analisis perusahaan pesaing

Volume dodolan mangsa ngarep perusahaan BIIB (Biogen)|NBIX (Neurocrine Biosciences, Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Regencell RGC|Prakiraan volume pendapatan perusahaan AXSM (Axsome Therapeutics Inc)|ACADIA Pharmaceuticals - Prakiraan volume dodolan|XENE - Prakiraan volume dodolan|VKTX: Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - Prakiraan volume dodolan|DNLI: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan harmonybiosciences.com (HRMY)|Biohaven - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan AMLX (amylyx.com)|Trevi Pharma (TRVI) - Volume dodolan sing dikarepake perusahaan|Praxis Corp - Prakiraan volume dodolan|Anavex Corp (AVXL) - Volume dodolan mangsa ngarep perusahaan|CBLL: Prakiraan volume dodolan|Prothena Biosciences - Pendapatan mangsa ngarep perusahaan|ALEC (alector.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan ANNX (Annexon Biosciences)|Prakiraan pendapatan perusahaan Omeros Corporation (OMER)|Neurogene Corp - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan AC Immune S.A. ACIU|Dodolan mangsa ngarep perusahaan Voyager Therapeutics (VYGR)|Neumora - Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan SCLX|Tevogen Bio Inc. (TVGN) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan ACOG|CGTX (cogrx.com) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan inhibikase.com (IKT)|Prakiraan pendapatan perusahaan Cassava Sciences Inc (SAVA)|Dodolan mangsa ngarep perusahaan Assertio|Prakiraan volume dodolan COYA (Coya Therapeutics, Inc.)|Prakiraan volume pendapatan perusahaan VTGN (VistaGen Therapeutics Inc)|OVID: Volume dodolan mangsa ngarep perusahaan|ABOS: Prakiraan pendapatan perusahaan|CervoMed (CRVO) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan PEPG (PepGen)|Volume dodolan mangsa ngarep perusahaan JUNS (Jupiter Neurosciences, Inc.)|Prakiraan volume dodolan relmada.com (RLMD)|Prakiraan pendapatan perusahaan Annovis Bio Corp ANVS|GRCE: Prakiraan pendapatan perusahaan|AIFF - Prakiraan pendapatan perusahaan|KLTO (anewmeds.com) - Prakiraan pendapatan perusahaan|NRSN (NeuroSense Therapeutics Ltd.) - Volume dodolan mangsa ngarep perusahaan|revivapharma.com - Pendapatan mangsa ngarep perusahaan|MTVA (metaviatx.com) - Prakiraan volume dodolan|NRXS: Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan HSDT|PASG - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan NEUP (Neuphoria Therapeutics)|NERV: Prakiraan pendapatan perusahaan|ADXN: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Cortigent (CRGT)|Prakiraan volume dodolan ATXI|BCLI - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan CARA (Cara Therapeutics, Inc)|Chromocell Therapeutics Corporation (CHRO) - Volume dodolan sing dikarepake perusahaan|ELYM - Prakiraan pendapatan perusahaan|Prakiraan dodolan perusahaan intracellulartherapies.com (ITCI)|Longboard (LBPH) - Prakiraan pendapatan perusahaan|Marinus Pharmaceuticals Inc - Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan NKGN|NeuroBo - Pendapatan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan Sage Therapeutics, Inc (SAGE)|Volume dodolan mangsa ngarep perusahaan Synaptogenix SNPX|Trevena, Inc. - Volume dodolan mangsa ngarep perusahaan|VIGL: Prakiraan pendapatan perusahaan|WENA: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Cerevel Therapeutics